Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis.
暂无分享,去创建一个
[1] K. Furie,et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.
[2] B. Psaty,et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. , 2007, Journal of the American College of Cardiology.
[3] P. Donnelly,et al. Replicating genotype–phenotype associations , 2007, Nature.
[4] I. Šteiner,et al. Bone formation in cardiac valves: a histopathological study of 128 cases , 2007, Virchows Archiv.
[5] Judy H Cho,et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.
[6] T. Hudson,et al. A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.
[7] Carolyn J. Brown,et al. A comprehensive analysis of common copy-number variations in the human genome. , 2007, American journal of human genetics.
[8] R. Hinton,et al. Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations , 2007, Human Genetics.
[9] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[10] S. Young,et al. Calcific Aortic Valve Stenosis in Old Hypercholesterolemic Mice , 2006, Circulation.
[11] J. Borer,et al. The epidemiology of valvular heart disease: a growing public health problem. , 2006, Heart failure clinics.
[12] J. Gardin,et al. Burden of valvular heart diseases: a population-based study , 2006, The Lancet.
[13] Hanlee P. Ji,et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. , 2006, Nature biotechnology.
[14] K. O’Brien. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[15] J. Erdmann,et al. Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. , 2006, Biochemical and biophysical research communications.
[16] R. Hinton,et al. Extracellular Matrix Remodeling and Organization in Developing and Diseased Aortic Valves , 2006, Circulation research.
[17] J. Després,et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. , 2006, Journal of the American College of Cardiology.
[18] P. Pibarot,et al. Distribution of SPARC during neovascularisation of degenerative aortic stenosis , 2006, Heart.
[19] R. Kronmal,et al. Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis , 2006, Circulation.
[20] R. Bonow,et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. , 2006, Journal of the American College of Cardiology.
[21] F. Hu,et al. A Common Genetic Variant Is Associated with Adult and Childhood Obesity , 2006, Science.
[22] V. Probst,et al. Familial Aggregation of Calcific Aortic Valve Stenosis in the Western Part of France , 2006, Circulation.
[23] P. Pibarot,et al. Expression of bone-regulatory proteins in human valve allografts , 2006, Heart.
[24] Maqc Consortium. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.
[25] J. Korf,et al. Microarray Profiling of Lymphocytes in Internal Diseases With an Altered Immune Response: Potential and Methodology , 2005, Mediators of inflammation.
[26] John D. Storey,et al. A network-based analysis of systemic inflammation in humans , 2005, Nature.
[27] P. Lévy,et al. Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells , 2005, FEBS letters.
[28] D. Srivastava,et al. Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.
[29] S. Stock,et al. Atorvastatin Inhibits Hypercholesterolemia-Induced Calcification in the Aortic Valves via the Lrp5 Receptor Pathway , 2005, Circulation.
[30] Rosario V. Freeman,et al. Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.
[31] A. Syvänen. Toward genome-wide SNP genotyping , 2005, Nature Genetics.
[32] R O Bonow,et al. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve , 2005, Heart.
[33] F. Dagenais,et al. Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. , 2005, The Journal of heart valve disease.
[34] J. Roos‐Hesselink,et al. Autosomal dominant inheritance of left ventricular outflow tract obstruction , 2005, American journal of medical genetics. Part A.
[35] S. Leal,et al. Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: Segregation, multiplex relative risk, and heritability , 2005, American journal of medical genetics. Part A.
[36] Frederick J Schoen,et al. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. , 2005, The Annals of thoracic surgery.
[37] S. Hagl,et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[38] W. Roberts,et al. Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation , 2005, Circulation.
[39] M. Daly,et al. Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.
[40] D. Clayton,et al. Genome-wide association studies: theoretical and practical concerns , 2005, Nature Reviews Genetics.
[41] J. Blanc,et al. Heterogeneous geographic distribution of patients with aortic valve stenosis: arguments for new aetiological hypothesis , 2005, Heart.
[42] K. Bussell. Signalling: Friendly rivalry , 2005, Nature Reviews Molecular Cell Biology.
[43] M. Olivier. A haplotype map of the human genome. , 2003, Nature.
[44] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[45] J. Epstein,et al. Detection of Cardiac Allograft Rejection and Response to Immunosuppressive Therapy With Peripheral Blood Gene Expression , 2004, Circulation.
[46] B. Horne,et al. Evidence for a Heritable Component in Death Resulting From Aortic and Mitral Valve Diseases , 2004, Circulation.
[47] M. Mäyränpää,et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. , 2004, Journal of the American College of Cardiology.
[48] David E Newby,et al. Calcific aortic stenosis: same old story? , 2004, Age and ageing.
[49] E. Lander,et al. Finishing the euchromatic sequence of the human genome , 2004 .
[50] Lisa J. Martin,et al. Bicuspid aortic valve is heritable. , 2004, Journal of the American College of Cardiology.
[51] S. Hagl,et al. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. , 2004, The Journal of heart valve disease.
[52] Paolo Fortina,et al. Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis. , 2004, Journal of molecular and cellular cardiology.
[53] Nathaniel Rothman,et al. Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .
[54] R. Autschbach,et al. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. , 2004, European heart journal.
[55] International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome , 2004 .
[56] B. Griffin,et al. Association Between Apolipoprotein E Alleles and Calcific Valvular Heart Disease , 2003, Circulation.
[57] S. Hagl,et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. , 2003, Atherosclerosis.
[58] Manuel Hidalgo,et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. , 2003, Cancer research.
[59] R. Lorentzon,et al. Oestrogen receptor α gene polymorphism is related to aortic valve sclerosis in postmenopausal women , 2003, Journal of internal medicine.
[60] B. Gersh,et al. CALCIFIC AORTIC STENOSIS: FROM BENCH TO THE BEDSIDE—EMERGING CLINICAL AND CELLULAR CONCEPTS , 2003, Heart.
[61] A. Tajik,et al. Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype , 2003, Circulation.
[62] E. Lakatta,et al. Sex- and age-dependent human transcriptome variability: Implications for chronic heart failure , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[63] Ash A. Alizadeh,et al. Individuality and variation in gene expression patterns in human blood , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[64] D. Khatry,et al. Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification , 2003, BMC Cancer.
[65] C. Otto,et al. Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma , 2002, Circulation.
[66] R. Hegele. SNP judgments and freedom of association. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[67] R. Bonow,et al. Atorvastatin Inhibits Hypercholesterolemia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve , 2002, Circulation.
[68] Steven C. Lawlor,et al. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.
[69] R. Aebersold,et al. Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers , 2001, Circulation research.
[70] A. Mansur,et al. Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis , 2001, Clinical genetics.
[71] W. Aronow,et al. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. , 2001, The American journal of cardiology.
[72] F. Ohme,et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis , 2001, Heart.
[73] Emile R. Mohler,et al. Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.
[74] R. Choudhury,et al. New insights into the progression of aortic stenosis: implications for secondary prevention. , 2000, Circulation.
[75] J. Shirani,et al. Matrix metalloproteinase expression in nonrheumatic aortic stenosis. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[76] E. Mohler. Are atherosclerotic processes involved in aortic-valve calcification? , 2000, The Lancet.
[77] R. Pai,et al. New insights into the progression of aortic stenosis: implications for secondary prevention. , 2000, Circulation.
[78] D. Stewart,et al. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. , 2000, Circulation.
[79] Bonnie K. Lind,et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. , 1999, The New England journal of medicine.
[80] JanNilsson,et al. Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves , 1999 .
[81] Freely associating , 1999, Nature Genetics.
[82] A. Hunter,et al. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. , 1997, Journal of the American College of Cardiology.
[83] G. Karsenty,et al. Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.
[84] C M Otto,et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.
[85] Catherine M. Otto,et al. Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .
[86] Bonnie K. Lind,et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.
[87] R. Tenconi,et al. Familial congenital bicuspid aortic valve: a disorder of uncertain inheritance. , 1996, American journal of medical genetics.
[88] C. Otto,et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[89] M. Ferguson,et al. Osteopontin is expressed in human aortic valvular lesions. , 1995, Circulation.
[90] J. Heikkilä,et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. , 1993, Journal of the American College of Cardiology.
[91] S. Beppu,et al. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. , 1993, The American journal of cardiology.
[92] W. Edwards,et al. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. , 1987, Mayo Clinic proceedings.
[93] W. Roberts. Anatomically isolated aortic valvular disease. The case against its being of rheumatic etiology. , 1970, The American journal of medicine.
[94] R. Scully,et al. AGING CHANGES IN THE AORTIC AND MITRAL VALVES. HISTOLOGIC AND HISTOCHEMICAL STUDIES, WITH OBSERVATIONS ON THE PATHOGENESIS OF CALCIFIC AORTIC STENOSIS AND CALCIFICATION OF THE MITRAL ANNULUS. , 1965, The American journal of pathology.